The Japanese investment holding company SoftBank Group (OTCPK:SFTBY) purchased two new stakes: 20.45M shares in Pacific Biosciences of California (PACB), and 14.66M shares in Recursion Pharmaceuticals ...
SoftBank Group (SFTBY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
7hOpinion
Zacks.com on MSNBest Momentum Stocks to Buy for February 14thHere are three stocks with buy rank and strong momentum characteristics for investors to consider today, February 14th: ...
SoftBank’s AI investments face increasing risks, especially in OpenAI and Stargate. Find out why SFTBF stock could be ...
For SoftBank Group Corp. investors looking for the stock to climb back to all-time highs on a revival of the artificial ...
Shares of AMD (AMD) and Intel (INTC) are in the spotlight on Thursday following a news report saying Arm (ARM) plans to launch its own chip ...
Arm (ARM) plans to launch its own chip this year after securing Meta (META) as one of its first customers, in a radical change to the SoftBank ...
Elon Musk is willing to yank his $97.4 billion bid for the nonprofit that oversees OpenAI if its directors agree to stop the transformation of the ChatGPT maker to a for-profit enterprise.
Q3 2025 Earnings Conference Call February 12, 2025 2:30 AM ETCompany ParticipantsYoshimitsu Goto - Board Director ...
Musk and his fellow investors submitted a $97.4 billion offer Monday for the nonprofit that controls OpenAI, according to the Wall Street Journal. The offer sets up a battle between Musk and Altman - ...
A drawn-out legal fight looms for Elon Musk and Sam Altman as they face an increasingly long courtroom battle over the future ...
Sam Altman to visit UAE to discuss fundraising with investment firm MGX amidst competition from China's DeepSeek and SoftBank ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results